Clinical Nuclear Medicine

Skip Navigation LinksHome > July 2013 - Volume 38 - Issue 7 > Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e318292aa2f
Interesting Images

Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in a Case of Pituitary Metastases

Hou, Yuantao MD; Zhu, Zhaohui MD*; Jin, Xiaona MD*; Wang, Renzhi MD; Xing, Bing MD

Collapse Box


Abstract: We compare 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT scans in a case of histologically proved pituitary metastases. The ratio of tumor to cerebellum (T/C) of 99mTc 3PRGD2 SPECT is much higher than that for 18F-FDG PET. We then conduct the same scans for a pituitary adenoma patient for better comparison. The T/C of 18F-FDG is not able to differentiate pituitary metastases from pituitary adenoma. However, The T/C of 99mTc 3PRGD2 observed in pituitary metastases was higher than that in pituitary adenoma.

© 2013 by Lippincott Williams & Wilkins


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.